======= GALNT11 ======= == Gene Information == * **Official Symbol**: GALNT11 * **Official Name**: polypeptide N-acetylgalactosaminyltransferase 11 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=63917|63917]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NCW6|Q8NCW6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GALNT11&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GALNT11|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615130|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Polypeptide N-acetylgalactosaminyltransferase that catalyzes the initiation of protein O-linked glycosylation and is involved in left/right asymmetry by mediating O-glycosylation of NOTCH1. O-glycosylation of NOTCH1 promotes activation of NOTCH1, modulating the balance between motile and immotile (sensory) cilia at the left-right organiser (LRO). Polypeptide N- acetylgalactosaminyltransferases catalyze the transfer of an N- acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Displays the same enzyme activity toward MUC1, MUC4, and EA2 than GALNT1. Not involved in glycosylation of erythropoietin (EPO). {ECO:0000269|PubMed:11925450, ECO:0000269|PubMed:24226769}. |Ricin B lectin| |Glycos transf 2| |protein O-linked glycosylation via threonine| |Notch receptor processing| |Notch signaling involved in heart development| |polypeptide N-acetylgalactosaminyltransferase activity| |cell surface receptor signaling pathway involved in heart development| |Notch binding| |O-glycan processing| |peptidyl-threonine modification| |regulation of Notch signaling pathway| |protein O-linked glycosylation| |determination of left/right symmetry| |determination of bilateral symmetry| |specification of symmetry| |Notch signaling pathway| |carbohydrate binding| |macromolecule glycosylation| |protein glycosylation| |glycosylation| |glycoprotein biosynthetic process| |cilium assembly| |cilium organization| |glycoprotein metabolic process| |pattern specification process| |plasma membrane bounded cell projection assembly| |cell projection assembly| |heart development| |carbohydrate derivative biosynthetic process| |Golgi membrane| |organelle assembly| |circulatory system development| |peptidyl-amino acid modification| |Golgi apparatus| |carbohydrate derivative metabolic process| |plasma membrane bounded cell projection organization| |cell projection organization| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-2.28| |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|-1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10828 * **Expression level (log2 read counts)**: 2.25 {{:chemogenomics:nalm6 dist.png?nolink |}}